Over halfway through the trading day on Tuesday, and the broad markets have yet to make up their minds. For the most part, the S&P 500 and Dow Jones industrial average have been trading sideways, albeit a little negative. The Nasdaq has picked up slightly, and the Russell 2000 is having the best showing out of the group.
With Congress finally coming to a consensus about another round of stimulus for the economy, investors would think that markets would be rallying on this positive news. However, Tuesday has proven to be a real stock-picker’s day.
To help divine which stocks could be rising or falling as a result of these developments, 24/7 Wall St. is taking a look at some big analyst calls that we have seen so far today. We have included the most recent analyst call on the stock, as well as a recent trading history and the general consensus among analysts.
For those that might have missed it, 24/7 Wall St. had an earlier round of analysts calls on Tuesday.
[nativounit]
Biogen Inc. (NASDAQ: BIIB | BIIB Price Prediction) was maintained as Buy at Canaccord Genuity. However, the firm did cut its price target to $359 from $393. The consensus price target is $291.40. Biogen stock was last seen trading at $248.08, in a 52-week range of $223.25 to $374.99.
Healthpeak Properties Inc. (NYSE: PEAK) was reiterated as Buy at Stifel with a $34 price target. The consensus price target is $30.56, and the stock was trading at $29.64. The 52-week range is $18.63 to $37.64.
IQVIA Holdings Inc. (NYSE: IQV) was reiterated at Stifel with a Buy rating and a $227 price target, compared to the most recent closing price of $176.75. The stock has traded in a range of $81.79 to $180.99 over the past 52 weeks. The consensus price target is $199.89.
Leslie’s Inc. (NASDAQ: LESL) was reiterated with a Buy rating and a $29 price target at Jefferies. The brokerage firm noted that Leslie’s is looking to build its outlook on what has been a record year. The stock was recently trading at $24.31, with a 52-week range of $19.15 to $25.84. Analysts have a consensus price target of $24.78.
[recirclink id=825676]
Lockheed Martin Corp. (NYSE: LMT) was reiterated as Hold by Jefferies and given a $400 price target, implying upside of 14% from the most recent closing price of $349.35. The consensus price target is $435.74. Lockheed Martin stock traded at $348.95, in its 52-week range of $266.11 to $442.53.
Kratos Defense & Security Solutions Inc. (NASDAQ: KTOS) was reiterated with a Buy rating and a $23 price target. Shares were trading at $26.12, with a consensus price target of $25.40. The stock has traded in a range of $5.00 to $26.90 over the past 52 weeks.
Peloton Interactive Inc. (NASDAQ: PTON) was reiterated as Outperform and its price target was raised to $162 from $142 at JMP Securities. Shares of Peloton were up 13% at $163.39, in a 52-week range of $17.70 to $166.23. The consensus price target is $136.33.
Square Inc. (NYSE: SQ) was reiterated with a Buy rating at BTIG Research, which also raised the price target to $295 from $220. Square stock was up about 2% at $237.54, with a consensus price target of $200.00. The stock has traded within a range of $32.33 to $242.58 over the past year.
Veeva Systems Inc. (NYSE: VEEV) was reiterated with a Buy rating and a $325 price target at Stifel. This compares with a consensus price target of $308.43. Veeva stock was up about 5% at 284.04, and it has a 52-week range of $118.11 to $313.99.
Ventas Inc. (NYSE: VTR) was reiterated with a Hold rating and a $47 price target at Stifel. This implies nearly a 4% downside from the most recent closing price of $48.83. The stock has a consensus price target of $46.37 and a 52-week range of $13.35 to $63.38.
Five top semiconductor companies not only have a long history of success and innovation, but their stocks still offer a reasonable upside to the Goldman Sachs 2021 price targets.
Also check out some of the biggest IPO losers of 2020, several of which came public before the pandemic hit.
[recirclink id=825762][wallst_email_signup]
Top Gaining Stocks
Top Losing Stocks